Diversified Trust CO Xencor Inc Transaction History

Diversified Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$18.21 - $24.5 $18,519 - $24,916	1,017 Added 7.79%	14,076 $266,000
Q1 2024 Apr 18, 2024	BUY	$18.65 - $26.52 $10,499 - $14,930	563 Added 4.51%	13,059 $288,000
Q4 2023 Jan 08, 2024	BUY	$16.53 - $21.42 $206,558 - $267,664	12,496 New	12,496 $265,000
Q2 2023 Jul 18, 2023	BUY	$24.77 - $29.9 $9,759 - $11,780	394 Added 3.62%	11,287 $281,000
Q1 2023 Apr 07, 2023	BUY	$25.95 - $36.95 $75,280 - $107,191	2,901 Added 36.3%	10,893 $303,000
Q4 2022 Jan 17, 2023	BUY	$24.79 - $30.86 $198,121 - $246,633	7,992 New	7,992 $208,000
Q2 2021 Jul 20, 2021	SELL	$34.33 - $44.68 $297,812 - $387,599	-8,675 Closed	0 $0
Q1 2021 May 10, 2021	SELL	$40.81 - $53.88 $36,443 - $48,114	-893 Reduced 9.33%	8,675 $374,000
Q3 2020 Oct 15, 2020	SELL	$30.09 - $43.02 $7,071 - $10,109	-235 Reduced 2.4%	9,568 $371,000
Q2 2020 Jul 07, 2020	BUY	$27.76 - $33.42 $272,131 - $327,616	9,803 New	9,803 $318,000

215

71.5M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.43B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Diversified Trust CO, based on Form 13F filings with the SEC.

Stay updated on Diversified Trust CO with notifications on news.